LEGEND BIOTECH CORP-ADR (LEGN) Stock Analyst Earnings Estimates
NASDAQ:LEGN - Nasdaq - US52490G1022 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 117M 70.06% | 285.143M 143.71% | 627.241M 119.97% | 1.037B 65.33% | 1.604B 54.68% | 2.174B 35.54% | 2.621B 20.56% | 3.02B 15.22% | 3.445B 14.07% | 3.741B 8.59% | 4.069B 8.77% | |
| EBITDA YoY % growth | -439.7M -15.68% | -507.515M -15.42% | -281.789M 44.48% | -134.025M 52.44% | 216.04M 261.19% | 618.42M 186.25% | 676.45M 9.38% | 915.06M 35.27% | 1.14B 24.58% | 1.267B 11.14% | 1.367B 7.89% | |
| EBIT YoY % growth | -458.1M -16.27% | -527.966M -15.25% | -305.148M 42.20% | -131.913M 56.77% | 171.85M 230.28% | 562.68M 227.43% | 951.59M 69.12% | 1.235B 29.78% | 1.516B 22.75% | 1.657B 9.30% | 1.848B 11.53% | |
| Operating Margin | -391.54% | -185.16% | -48.65% | -12.72% | 10.71% | 25.88% | 36.31% | 40.89% | 44.01% | 44.29% | 45.42% | |
| EPS YoY % growth | N/A -9.10% | -2.96 -100.97% | -0.95 67.91% | -0.57 39.73% | 0.59 203.55% | 1.05 77.84% | 1.41 33.59% | 1.91 35.84% | 2.57 34.34% | 3.02 17.46% | 3.51 16.22% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 -53.00% | -0.07 90.25% | -0.01 -105.95% | 0.06 111.81% | 0.27 273.33% | 0.37 653.85% | 0.46 5,242.86% |
| Revenue Q2Q % growth | 232.88M 24.85% | 283.12M 76.72% | 332.82M 78.43% | 335.95M 72.24% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -49.402M -59.99% | -22.406M 58.35% | -8.568M 83.40% | -17.34M 61.85% | 11.22M 122.71% | 16.32M 172.84% | 25.5M 397.62% |
| EBIT Q2Q % growth | -45.549M -8.53% | -16.306M 76.82% | 1.548M 102.07% | -11.386M 77.52% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.54 -68.75% | -0.24 | -0.30 | -127.98% |
| Q4 2024 Q2Q % growth | 0.15 118.75% | -0.34 | 0.49 | 143.99% |
| Q3 2024 Q2Q % growth | -0.68 -100.00% | -0.45 | -0.23 | -52.09% |
| Q2 2024 Q2Q % growth | -0.10 91.23% | -0.39 | 0.29 | 74.28% |
| Q1 2024 Q2Q % growth | -0.32 52.94% | -0.35 | 0.03 | 8.88% |
| Q4 2023 Q2Q % growth | -0.80 -78.66% | -0.85 | 0.05 | 5.50% |
| Q3 2023 Q2Q % growth | -0.34 17.29% | -0.69 | 0.35 | 50.80% |
| Q2 2023 Q2Q % growth | -1.14 8.06% | -0.61 | -0.53 | -86.27% |
| Q1 2023 Q2Q % growth | -0.68 -161.54% | -0.80 | 0.12 | 14.53% |
| Q4 2022 Q2Q % growth | -49.26% | -0.45 | % | |
| Q3 2022 Q2Q % growth | 4.40% | -0.41 | % | |
| Q2 2022 Q2Q % growth | -1.24 -287.50% | -0.43 | -0.81 | -188.69% |
| Q1 2022 Q2Q % growth | -0.26 13.33% | -0.47 | 0.21 | 44.59% |
| Q4 2021 Q2Q % growth | -0.30 -36.36% | -0.42 | 0.12 | 28.26% |
| Q3 2021 Q2Q % growth | -0.43 14.00% | -0.36 | -0.07 | -18.75% |
| Q2 2021 Q2Q % growth | -0.32 74.60% | -0.34 | 0.02 | 7.04% |
| Q1 2021 Q2Q % growth | -0.30 | -0.36 | 0.06 | 15.97% |
| Q4 2020 Q2Q % growth | -0.22 | -0.29 | 0.07 | 23.87% |
| Q3 2020 Q2Q % growth | -0.50 | -0.31 | -0.19 | -59.84% |
| Q2 2020 Q2Q % growth | -1.26 | -0.27 | -0.99 | -375.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 195.053M 107.52% | 197.49M | -2.437M | -1.23% |
| Q4 2024 Q2Q % growth | 186.522M 134.73% | 182.51M | 4.012M | 2.20% |
| Q3 2024 Q2Q % growth | 160.205M 66.86% | 146.75M | 13.455M | 9.17% |
| Q2 2024 Q2Q % growth | 186.523M 154.36% | 129.12M | 57.403M | 44.46% |
| Q1 2024 Q2Q % growth | 93.991M 158.67% | 155.68M | -61.689M | -39.63% |
| Q4 2023 Q2Q % growth | 79.464M -32.08% | 88.08M | -8.616M | -9.78% |
| Q3 2023 Q2Q % growth | 96.013M 209.45% | 99.229M | -3.216M | -3.24% |
| Q2 2023 Q2Q % growth | 73.33M 512.61% | 55.71M | 17.62M | 31.63% |
| Q1 2023 Q2Q % growth | 36.336M -27.39% | 40.622M | -4.286M | -10.55% |
| Q4 2022 Q2Q % growth | 117.005M 548.95% | 37.221M | 79.784M | 214.35% |
| Q3 2022 Q2Q % growth | 83.81% | 31.027M | % | |
| Q2 2022 Q2Q % growth | 11.97M -40.83% | 32.325M | -20.355M | -62.97% |
| Q1 2022 Q2Q % growth | 50.04M 265.79% | 17M | 33.04M | 194.35% |
| Q4 2021 Q2Q % growth | 18.03M -55.05% | 14.51M | 3.52M | 24.26% |
| Q3 2021 Q2Q % growth | 16.88M 43.66% | 7.99M | 8.89M | 111.26% |
| Q2 2021 Q2Q % growth | 20.23M 74.40% | 9.316M | 10.914M | 117.15% |
| Q1 2021 Q2Q % growth | 13.68M 18.44% | 4.42M | 9.26M | 209.50% |
| Q4 2020 Q2Q % growth | 40.11M 80.92% | 13.26M | 26.85M | 202.49% |
| Q3 2020 Q2Q % growth | 11.75M -33.50% | 13.26M | -1.51M | -11.39% |
| Q2 2020 Q2Q % growth | 11.6M 14.97% | 13.26M | -1.66M | -12.52% |
| Q1 2020 Q2Q % growth | 11.55M 14.93% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 13.46% | 31.19% | 8.26% | 20.24% |
| Revenue | -3.61% | -6.56% | -0.1% | -0.38% |